Menu
GWAS Study

Developmental language disorder - a comprehensive study of more than 46,000 individuals.

Nudel R, Christensen RV, Kalnak N et al.

36963307 PubMed ID
GWAS Study Type
18380 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

NR
Nudel R
CR
Christensen RV
KN
Kalnak N
SM
Schwinn M
BK
Banasik K
DK
Dinh KM
EC
Erikstrup C
PO
Pedersen OB
BK
Burgdorf KS
UH
Ullum H
OS
Ostrowski SR
HT
Hansen TF
WT
Werge T
Chapter II

Abstract

Summary of the research findings

Developmental language disorder (DLD) is characterized by enduring low language abilities with a significant functional impact, in the absence of biomedical conditions in which language impairment is part of a complex of impairments. There is a lack of awareness of DLD even among healthcare professionals. Here we estimated the prevalence of DLD and its links to reading and learning difficulties and physical and mental health in the Danish Blood Donor Study (N = 46,547), where DLD-related information is based on questionnaires (self-report). We compared the questionnaire-derived DLD status with the relevant language-related diagnoses from hospital registers. We also investigated the genetic architecture of DLD in a subset of the cohort (N = 18,380). DLD was significantly associated with reading and learning difficulties and poorer mental and physical health. DLD prevalence was 3.36%-3.70% based on questionnaires, compared with 0.04% in hospital registers. Our genetic analyses identified one genome-wide significant locus, but not a significant heritability estimate. Our study shows that DLD has health-related implications that may last into adulthood, and that DLD may be undiagnosed in general healthcare. Furthermore, DLD is likely more genetically heterogeneous than narrower developmental language phenotypes. Our results emphasize the need to raise awareness of DLD and consider criteria for molecular studies of DLD to reduce case heterogeneity.

610 European ancestry cases, 17,770 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

18380
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.